Practical lessons from treating medullary thyroid carcinoma patients harboring a RET-alteration: Pralsetinib-induced acute confusional state

Authors

  • Eliya Shachar Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Division of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
  • Shira Peleg Hasson Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Division of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
  • Deborah T. Blumenthal Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Division of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
  • Meerav Fraenkel Endocrinology Unit, Soroka University Medical Center, Beer-Sheva, Israel;d Faculty of health science, Ben-Gurion University of the Negev, Beer-Sheva, Israel
  • Yoel Uri Endocrinology Unit, Soroka University Medical Center, Beer-Sheva, Israel; Faculty of health science, Ben-Gurion University of the Negev, Beer-Sheva, Israel
  • Ido Wolf Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Division of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
  • Simona Grozinsky-Glasberg Neuroendocrine Tumor Unit, ENETS Center of Excellence, Endocrinology and Metabolism Department, Hadassah Medical Organization and Faculty of Medicine, Jerusalem, Israel; Hebrew University of Jerusalem, Jerusalem, Israel

DOI:

https://doi.org/10.1080/0284186X.2022.2071111

Abstract

No Abstracts available

Downloads

Download data is not yet available.

Downloads

Published

2022-07-03

How to Cite

Shachar, E., Peleg Hasson, S., Blumenthal, D. T., Fraenkel, M., Uri, Y., Wolf, I., & Grozinsky-Glasberg, S. (2022). Practical lessons from treating medullary thyroid carcinoma patients harboring a RET-alteration: Pralsetinib-induced acute confusional state. Acta Oncologica, 61(7), 819–823. https://doi.org/10.1080/0284186X.2022.2071111

Issue

Vol. 61 No. 7 (2022): Acta Oncologica

Section

Articles